Frequent Occult Infection with Cytomegalovirus in Cardiac Transplant Recipients despite Antiviral Prophylaxis
- 1 June 2007
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 45 (6) , 1804-1810
Abstract
Despite antiviral prophylaxis, a high percentage (over 90%) of heart transplant patients experience active cytomegalovirus (CMV) infection, diagnosed by detection of viral DNA in peripheral blood polymorphonuclear leukocytes within the first few months posttransplantation. Viral DNA was detected in mononuclear cells prior to detection in granulocytes from CMV-seropositive recipients (R + ) receiving a heart from a CMV-seropositive donor (D + ). Based on assessment of systemic infection in leukocyte populations, both R + subgroups (R + /D − and R + /D + ) experienced a greater infection burden than the R − /D + subgroup, which was aggressively treated because of a higher risk of acute CMV disease. Despite widespread systemic infection in all at-risk patient subgroups, CMV DNA was rarely (+ patients more frequently exceeded the 75th percentile of the CMV DNA copy number distribution in leukocytes (110 copies/10 5 polymorphonuclear leukocytes) than the R − /D + subgroup. Therefore, active systemic CMV infection involving leukocytes is common in heart transplant recipients receiving prophylaxis to reduce acute disease. Infection of the transplanted organ is rare, suggesting that chronic vascular disease attributed to CMV may be driven by the consequences of systemic infection.Keywords
This publication has 22 references indexed in Scilit:
- T-Cell Immunity to Subclinical Cytomegalovirus Infection Reduces Cardiac Allograft DiseaseCirculation, 2006
- Acute Rejection and Cardiac Allograft Vascular Disease Is Reduced by Suppression of Subclinical Cytomegalovirus InfectionTransplantation, 2006
- Immune activation following cytomegalovirus infection: More important than direct viral effects in cardiovascular disease?Journal of Clinical Virology, 2006
- Quantitative Real-Time PCR Assays for Detection of Human Adenoviruses and Identification of Serotypes 40 and 41Applied and Environmental Microbiology, 2005
- Human Cytomegalovirus (HCMV) Replication Dynamics in HCMV‐Naive and ‐Experienced Immunocompromised HostsThe Journal of Infectious Diseases, 2002
- Latency and Reactivation of Human CytomegalovirusJournal of Infection, 2002
- Allograft Rejection Predicts the Occurrence of Late‐Onset Cytomegalovirus (CMV) Disease among CMV‐Mismatched Solid Organ Transplant Patients Receiving Prophylaxis with Oral GanciclovirThe Journal of Infectious Diseases, 2001
- IMPACT OF CYTOMEGALOVIRUS HYPERIMMUNE GLOBULIN ON OUTCOME AFTER CARDIOTHORACIC TRANSPLANTATIONTransplantation, 2001
- Diagnosis of human cytomegalovirus infections in the immunocompromised hostClinical and Diagnostic Virology, 1996
- Human Cytomegalovirus Infection of the Major Leukocyte Subpopulations and Evidence for Initial Viral Replication in Polymorphonuclear Leukocytes from Viremic PatientsThe Journal of Infectious Diseases, 1992